Biotech Stock News (CLDN) (BLUE) (QURE) (ONCE) (CANF) (AMGN) (MRK) (BMY)

Celladon Corporation (NASDAQ:CLDN) On April 26, 2015 Shares of Celladon Corporation tumbled 80% in one day after the company reported that its phase 2 trial using Mydicar to treat heart failure patients failed to meet on both the primary endpoint and the secondary endpoint. The phase 2 trial was known as CUPID-2 and recruited up … Read more

Biotech Stock News (ARWR)(AMGN)(ATHX)(PFE)

Arrowhead Research Corp (NASDAQ:ARWR) On April 13, 2015 Arrowhead announced that it was given the go-ahead by the FDA to begin treating patients in the phase 2b Hepatitis B study. ┬áThe drug compound being used in the study is known as ARC-520 which is an RNAi drug. RNAi stands for RNA interference and these types … Read more